Profilo
Eamonn Connolly worked as the Head of the Research Department at BioGaia AB from 2010 to 2011.
He then served as the Chief Scientific Officer at Infant Bacterial Therapeutics AB from 2013 to 2021.
Dr. Connolly obtained an undergraduate degree from The University of Manchester and a doctorate degree from the University of Manchester Institute of Science & Technology.
Precedenti posizioni note di Eamonn Connolly
| Società | Posizione | Fine |
|---|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Direttore Tecnico/Scientifico/R&S | 01/01/2021 |
| BIOGAIA AB | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Eamonn Connolly
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
BioGaia AB
BioGaia AB Pharmaceuticals: OtherHealth Technology Develops health care products such as foods with healthy additives and provides pharmaceutical research services | Health Technology |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manchester Institute of Science & Technology
University of Manchester Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of gastroschisis | Health Technology |
















